FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897946234> ?p ?o ?g. }

• W2897946234 endingPage "88" @default.
• W2897946234 startingPage "80" @default.
• W2897946234 abstract "Abstract During the treatment of acute lymphoblastic leukemia (ALL) with asparaginase (ASN) there is an accumulation of ammonia in the body as result of asparagine hydrolysis. This accumulation known as hyperammonemia is one of the main side-effects of this therapy. To avoid hyperammonemia is urgent to develop new strategies for ammonia retention. Herein is presented the immobilization of ASN into bovine serum albumin/poloxamer 407 (BSA/Pol407) nanoparticles. The ability of the developed nanoparticles to hydrolyze asparagine while retaining the forming ammonia is also explored. Different percentages of ASN were entrapped into BSA nanoparticles coated with Poloxamer 407 and were prepared by high-pressure homogenization. The nanoparticles were characterized regarding their physico-chemical properties, stability, capacity to retain ammonia and safety using zebrafish embryos as an in vivo model of toxicity. The BSA/ASN25%/Pol407 nanoparticles were selected as the best formulation to hydrolyze asparagine using the lowest nanoparticle concentration. These nanoparticles presented physical characteristics suitable for an intravenous application and were capable to retain the forming ammonia decreasing the negative effect of free ASN on zebrafish survival. These nanoparticles could potentially be used to prevent hyperammonemia during ALL treatment with ASN." @default.
• W2897946234 created "2018-10-26" @default.
• W2897946234 creator A5004925897 @default.
• W2897946234 creator A5010628570 @default.
• W2897946234 creator A5013192136 @default.
• W2897946234 creator A5024848049 @default.
• W2897946234 creator A5032796498 @default.
• W2897946234 creator A5044116003 @default.
• W2897946234 creator A5077858872 @default.
• W2897946234 date "2019-01-01" @default.
• W2897946234 modified "2023-10-18" @default.
• W2897946234 title "BSA/ASN/Pol407 nanoparticles for acute lymphoblastic leukemia treatment" @default.
• W2897946234 cites W1524819384 @default.
• W2897946234 cites W1615535881 @default.
• W2897946234 cites W1683632289 @default.
• W2897946234 cites W1983644560 @default.
• W2897946234 cites W1984021946 @default.
• W2897946234 cites W1988937184 @default.
• W2897946234 cites W1990449508 @default.
• W2897946234 cites W2004476458 @default.
• W2897946234 cites W2008283467 @default.
• W2897946234 cites W2009264592 @default.
• W2897946234 cites W2017695960 @default.
• W2897946234 cites W2020424034 @default.
• W2897946234 cites W2036378675 @default.
• W2897946234 cites W2054038164 @default.
• W2897946234 cites W2054672519 @default.
• W2897946234 cites W2059247083 @default.
• W2897946234 cites W2062025036 @default.
• W2897946234 cites W2063318887 @default.
• W2897946234 cites W2069873775 @default.
• W2897946234 cites W2084879398 @default.
• W2897946234 cites W2085442218 @default.
• W2897946234 cites W2088708637 @default.
• W2897946234 cites W2125349610 @default.
• W2897946234 cites W2132753522 @default.
• W2897946234 cites W2138334551 @default.
• W2897946234 cites W2141859770 @default.
• W2897946234 cites W2144652393 @default.
• W2897946234 cites W2152621767 @default.
• W2897946234 cites W2192049920 @default.
• W2897946234 cites W2258910543 @default.
• W2897946234 cites W2312126744 @default.
• W2897946234 cites W2419982124 @default.
• W2897946234 cites W2433139937 @default.
• W2897946234 cites W2770758857 @default.
• W2897946234 doi "https://doi.org/10.1016/j.bej.2018.10.006" @default.
• W2897946234 hasPublicationYear "2019" @default.
• W2897946234 type Work @default.
• W2897946234 sameAs 2897946234 @default.
• W2897946234 citedByCount "3" @default.
• W2897946234 countsByYear W28979462342020 @default.
• W2897946234 countsByYear W28979462342022 @default.
• W2897946234 crossrefType "journal-article" @default.
• W2897946234 hasAuthorship W2897946234A5004925897 @default.
• W2897946234 hasAuthorship W2897946234A5010628570 @default.
• W2897946234 hasAuthorship W2897946234A5013192136 @default.
• W2897946234 hasAuthorship W2897946234A5024848049 @default.
• W2897946234 hasAuthorship W2897946234A5032796498 @default.
• W2897946234 hasAuthorship W2897946234A5044116003 @default.
• W2897946234 hasAuthorship W2897946234A5077858872 @default.
• W2897946234 hasBestOaLocation W28979462342 @default.
• W2897946234 hasConcept C126322002 @default.
• W2897946234 hasConcept C155672457 @default.
• W2897946234 hasConcept C171250308 @default.
• W2897946234 hasConcept C185592680 @default.
• W2897946234 hasConcept C192562407 @default.
• W2897946234 hasConcept C2778461978 @default.
• W2897946234 hasConcept C2909962599 @default.
• W2897946234 hasConcept C502942594 @default.
• W2897946234 hasConcept C71924100 @default.
• W2897946234 hasConceptScore W2897946234C126322002 @default.
• W2897946234 hasConceptScore W2897946234C155672457 @default.
• W2897946234 hasConceptScore W2897946234C171250308 @default.
• W2897946234 hasConceptScore W2897946234C185592680 @default.
• W2897946234 hasConceptScore W2897946234C192562407 @default.
• W2897946234 hasConceptScore W2897946234C2778461978 @default.
• W2897946234 hasConceptScore W2897946234C2909962599 @default.
• W2897946234 hasConceptScore W2897946234C502942594 @default.
• W2897946234 hasConceptScore W2897946234C71924100 @default.
• W2897946234 hasLocation W28979462341 @default.
• W2897946234 hasLocation W28979462342 @default.
• W2897946234 hasOpenAccess W2897946234 @default.
• W2897946234 hasPrimaryLocation W28979462341 @default.
• W2897946234 hasRelatedWork W1672177754 @default.
• W2897946234 hasRelatedWork W2072207948 @default.
• W2897946234 hasRelatedWork W2407161884 @default.
• W2897946234 hasRelatedWork W2410889947 @default.
• W2897946234 hasRelatedWork W2429291258 @default.
• W2897946234 hasRelatedWork W2724221850 @default.
• W2897946234 hasRelatedWork W2748952813 @default.
• W2897946234 hasRelatedWork W2770032321 @default.
• W2897946234 hasRelatedWork W2899084033 @default.
• W2897946234 hasRelatedWork W4249127011 @default.
• W2897946234 hasVolume "141" @default.
• W2897946234 isParatext "false" @default.
• W2897946234 isRetracted "false" @default.
• W2897946234 magId "2897946234" @default.

• next